TP53 and neoplasm: More importantly, MAML1, as a major transcriptional co-activator for Notch signaling, activates multiple signaling pathways that are dysregulated in tumor cells, including p53, NF-κB, and Wnt/β-catenin, to promote tumor development [28–31].